Roche Diagnostics Files PD-L1 Test Kit for Imfinzi in Japan

Roche Diagnostics said on December 7 that it filed Ventana PD-L1 (SP263) Assay (overseas brand name), a PD-L1 expression test kit for AstraZeneca’s anti-PD-L1 antibody Imfinzi (durvalumab), in Japan on November 28. Ventana PD-L1 is a qualitative immunohistochemical assay kit...read more